DECAPHARMA financials
A multi-period view of the public annual-account figures reported for DECAPHARMA, with comparable measures and links to available source documents.
Company overviewRegistry number
0828116714
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for DECAPHARMA
2025 versus 2024
- Operating line
- €65,566
- EBITDA
- €39,490
- Total assets
- €291,134
- Equity
- €105,083
+14%
+40.5%
-1.5%
+3.3%
EBITDA margin +60.2% · Equity ratio +36.1%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.